Mackenzie Financial Corp Bioventus Inc. Transaction History
Mackenzie Financial Corp
- $71.1 Billion
- Q4 2024
A detailed history of Mackenzie Financial Corp transactions in Bioventus Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 32,266 shares of BVS stock, worth $235,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,266
Previous 32,266
-0.0%
Holding current value
$235,864
Previous $338,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BVS
# of Institutions
156Shares Held
45.2MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$95.2 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$50.7 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$29.4 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17.3 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $451M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...